Filter
1250
Text search:
pharmaceutical
situation
Featured
Recommendations
118
New Publications
329
Language
Document type
No document type
627
Studies & Reports
249
Guidelines
199
Strategic & Response Plan
64
Manuals
55
Fact sheets
17
Training Material
15
Situation Updates
14
Resource Platforms
5
Infographics
4
Brochures
1
Countries / Regions
Ethiopia
57
Kenya
53
India
46
South Africa
36
Global
36
Nigeria
34
Western and Central Europe
34
Sierra Leone
31
Uganda
31
Liberia
25
Ghana
25
Tanzania
22
Namibia
19
Ukraine
19
Malawi
18
Zambia
15
Rwanda
15
Latin America and the Carribbean
15
Nepal
14
Syria
14
Eastern Europe
14
Philippines
13
Africa
13
Indonesia
12
Bangladesh
12
Zimbabwe
11
Cambodia
11
Congo, Democratic Republic of
10
Lesotho
9
Myanmar / Burma
9
South–East Asia Region
9
Germany
8
Cameroon
7
Thailand
6
Botswana
6
West and Central Africa
6
Asia
6
Venezuela
6
Vietnam
6
South Sudan
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Albania
5
Burkina Faso
4
Senegal
4
Haiti
4
China
4
Papua New Guinea
4
Laos
4
Guinea
3
Mali
3
Pakistan
3
Jordan
3
Egypt
3
Mozambique
3
Benin
3
Middle East and North Africa
3
Western Pacific Region
3
Fiji
3
Iraq
2
Sudan
2
Central African Republic
2
Brazil
2
North Macedonia
2
Chile
2
East and Southern Africa
2
Lithuania
2
Moldova
2
Jamaica
2
USA
1
Niger
1
Somalia
1
Afghanistan
1
Lebanon
1
Chad
1
Ireland
1
Peru
1
Serbia
1
El Salvador
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Bulgaria
1
Romania
1
Iran
1
Kyrgyzstan
1
Georgia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
558
Key Resources
70
Clinical Guidelines
64
Public Health
47
Women & Child Health
27
Pharmacy & Technologies
17
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
143
COVID-19
125
Pharmacy
96
Mental Health
73
TB
52
HIV
42
Rapid Response
29
Conflict
28
NTDs
28
Planetary Health
25
Ebola & Marburg
24
Global Health Education
23
Caregiver
22
NCDs
20
Malaria
16
Health Financing Toolbox
15
2.0 Rapid Response
11
Disability
7
Polio
7
Refugee
7
Natural Hazards
6
Specific Hazards
6
Zika
4
Cholera
2
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated i
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improv
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation
...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,
...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibio
...
Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. E
...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a com
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and
...
This document has been developed as a guide to allinstitutions producing health care waste in planning and implementation of interventions that will reduce mismanagement of hazardous waste in Zambia.The National Health-Care Waste Management Plan for 2015 to 2019 provides an overv
...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
